Open access
1,518
Views
24
CrossRef citations to date
0
Altmetric
Research Paper
Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates
Marwa G. El-GazzarDepartment of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt; Correspondence[email protected]
, Nessma H. NafieDepartment of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt;
, Alessio NocentiniNEUROFARBA Department, Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Firenze, Italy
, Mostafa M. GhorabDepartment of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt;
, Helmi I. HeibaDepartment of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt;
& Claudiu T. SupuranNEUROFARBA Department, Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Firenze, ItalyCorrespondence[email protected]
http://orcid.org/0000-0003-4262-0323
http://orcid.org/0000-0003-4262-0323
Pages 1565-1574
|
Received 27 Jul 2018, Accepted 16 Aug 2018, Published online: 02 Oct 2018
Related Research Data
Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition.
Source:
Impact Journals, LLC
Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids.
Source:
Informa UK Limited
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Source:
Springer Science and Business Media LLC
Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Source:
Elsevier BV
New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors
Source:
Elsevier BV
Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors
Source:
Elsevier BV
Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
Source:
Georg Thieme Verlag KG
Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Source:
Elsevier BV
Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
Source:
Elsevier BV
Carbonic anhydrase inhibitors
Source:
Elsevier BV
Targeting carbonic anhydrase IX with small organic ligands.
Source:
Elsevier BV
Carbonic anhydrase inhibitory properties of some uracil derivatives.
Source:
Taylor & Francis Ltd
Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids.
Source:
Elsevier BV
Carbonic anhydrase inhibition and the management of neuropathic pain.
Source:
Informa UK Limited
Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties
Source:
HAL CCSD
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases
Source:
American Chemical Society (ACS)
Sulfonamide inhibition studies of two β-carbonic anhydrases from the ascomycete fungus Sordaria macrospora, CAS1 and CAS2
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.